ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,688,000 | +525.2% | 41,752 | +789.7% | 0.02% | +433.3% |
| Q2 2015 | $270,000 | -65.3% | 4,693 | -61.5% | 0.00% | -62.5% |
| Q1 2015 | $777,000 | -25.9% | 12,200 | -28.2% | 0.01% | +14.3% |
| Q4 2014 | $1,049,000 | +86.3% | 17,000 | +17.2% | 0.01% | +133.3% |
| Q3 2014 | $563,000 | -61.6% | 14,500 | -66.0% | 0.00% | -57.1% |
| Q2 2014 | $1,468,000 | -39.8% | 42,600 | -24.5% | 0.01% | -50.0% |
| Q1 2014 | $2,439,000 | -37.0% | 56,455 | -41.9% | 0.01% | -33.3% |
| Q4 2013 | $3,869,000 | +37.1% | 97,129 | +29.2% | 0.02% | +16.7% |
| Q3 2013 | $2,821,000 | +41.3% | 75,151 | +1.2% | 0.02% | +50.0% |
| Q2 2013 | $1,996,000 | – | 74,287 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |